Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

Clinical trial NCT02603679 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02603679
Sponsor: Thomas Hatschek
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early-Stage Breast Carcinoma Estrogen Receptor Positive Tumor

Start date: 2015-02-01
Primary completion: 2021-07-30
Enrollment: 181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.